{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:23:24Z","timestamp":1791602604246,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Food ladders are tools designed to facilitate home-based dietary advancement in children with food allergies through stepwise exposures to increasingly allergenic forms of milk and egg. Several studies have now documented safety and efficacy of food ladders. In 2021, we published a Canadian adaptation of the previously existing milk and egg ladders originating in Europe using foods more readily available\/consumed in Canada. Our study adds to the growing body of evidence supporting food ladder use and provides safety and effectiveness data for our Canadian adaptation of the milk and egg ladders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Surveys were distributed to families of children using the Canadian Milk Ladder and\/or the Canadian Egg Ladder at baseline, with follow up surveys at 3 months, 6 months, and 12 months. Data were analyzed using REDCap and descriptive and inferential statistics are presented.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>One hundred and nine participants were started on milk\/egg ladders between September 2020 and June 2022. 53 participants responded to follow up surveys. Only 2 of 53 (3.8%) participants reported receiving epinephrine during the study. Severe grade 4 reactions (defined according to the modified World Allergy Organization grading system) were not reported by any participants. Minor cutaneous adverse reactions were common, with about 71% (n\u2009=\u200910\/14) of respondents reporting cutaneous adverse reactions by 1 year of food ladder use. An increasing proportion of participants could tolerate most foods from steps 2\u20134 foods after 3, 6, and 12 months of the food ladder compared to baseline.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The Canadian food ladders are safe tools for children with cow\u2019s milk and\/or egg allergies, and participants tolerated a larger range of foods with food ladder use compared to baseline.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13223-023-00847-7","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T14:02:09Z","timestamp":1699279329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Safety and effectiveness of the Canadian food ladders for children with IgE-mediated food allergies to cow\u2019s milk and\/or egg"],"prefix":"10.1186","volume":"19","author":[{"given":"Alanna","family":"Chomyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond S.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert T.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy K.","family":"Vander Leek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brock A","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne","family":"Soller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa M.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3870-9114","authenticated-orcid":false,"given":"Tiffany","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,6]]},"reference":[{"issue":"4","key":"847_CR1","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.jaip.2019.10.021","volume":"8","author":"AE Clarke","year":"2020","unstructured":"Clarke AE, Elliott S, St-Pierre Y, Soller L, La Vieille S, Ben-Shoshan M. Temporal Trends in Prevalence of Food Allergy in Canada. J Allergy Clin Immunol Pract; April. 2020;8(4):1428\u201330.","journal-title":"J Allergy Clin Immunol Pract; April"},{"issue":"4","key":"847_CR2","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jaci.2015.11.015","volume":"137","author":"LB Grabenhenrich","year":"2016","unstructured":"Grabenhenrich LB, D\u00f6lle S, Moneret-Vautrin A, K\u00f6hli A, Lange L, Spindler T, et al. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. J Allergy Clin Immunol. 2016;137(4):1128\u20131137e1.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"847_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jaip.2018.11.038","volume":"7","author":"T Sinai","year":"2019","unstructured":"Sinai T, Goldberg MR, Nachshon L, Amitzur-Levy R, Yichie T, Katz Y, et al. Reduced Final Height and Inadequate Nutritional Intake in Cow\u2019s Milk-Allergic Young Adults. J Allergy Clin Immunol Pract. 2019;7(2):509\u201315.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"847_CR4","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/apa.13044","volume":"104","author":"JL Protudjer","year":"2015","unstructured":"Protudjer JL, Jansson SA, \u00d6stblom E, Arnlind MH, Bengtsson U, Dahl\u00e9n SE. Health-related quality of life in children with objectively diagnosed staple food allergy assessed with a disease-specific questionnaire. Acta Paediatr. 2015;104(10):1047\u201354. https:\/\/doi.org\/10.1111\/apa.13044. Epub 2015 Jul 6. PMID: 25983039.","journal-title":"Acta Paediatr"},{"issue":"1","key":"847_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.anai.2014.04.016","volume":"113","author":"L Howe","year":"2014","unstructured":"Howe L, Franxman T, Teich E, Greenhawt M. What affects quality of life among caregivers of food-allergic children? Ann Allergy Asthma Immunol. 2014;113(1):69. https:\/\/doi.org\/10.1016\/j.anai.2014.04.016. 4e2.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6 Pt 3","key":"847_CR6","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1542\/peds.111.S3.1631","volume":"111","author":"RA Wood","year":"2003","unstructured":"Wood RA. The natural history of food allergy. Pediatrics. 2003;111(6 Pt 3):1631\u20137.","journal-title":"Pediatrics"},{"issue":"3","key":"847_CR7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jaci.2012.10.060","volume":"131","author":"RA Wood","year":"2013","unstructured":"Wood RA, Sicherer SH, Vickery BP, Jones SM, Liu AH, Fleischer DM, et al. The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol. 2013;131(3):805\u201312. https:\/\/doi.org\/10.1016\/j.jaci.2012.10.060. Epub 2012 Dec 28.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"847_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jaci.2013.12.1041","volume":"133","author":"SH Sicherer","year":"2014","unstructured":"Sicherer SH, Wood RA, Vickery BP, Jones SM, Liu AH, Fleischer DM, et al. The natural history of egg allergy in an observational cohort. J Allergy Clin Immunol. 2014;133(2):492\u20139. https:\/\/doi.org\/10.1016\/j.jaci.2013.12.1041.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"847_CR9","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1542\/peds.2011-1762","volume":"130","author":"DM Fleischer","year":"2012","unstructured":"Fleischer DM, Perry TT, Atkins D, Wood RA, Burks AW, Jones SM, Henning AK, Stablein D, Sampson HA, Sicherer SH. Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study. Pediatrics. 2012;130(1):e25. Epub 2012 Jun 25.","journal-title":"Pediatrics"},{"issue":"1","key":"847_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jaip.2019.06.034","volume":"8","author":"E Hsu","year":"2020","unstructured":"Hsu E, Soller L, Abrams EM, Protudjer JLP, Mill C, Chan ES. Oral Food Challenge Implementation: The First Mixed-Methods Study Exploring Barriers and Solutions. J Allergy Clin Immunol Pract. 2020;8(1):149\u2013156e1. https:\/\/doi.org\/10.1016\/j.jaip.2019.06.034. Epub 2019 Jul 10. PMID: 31301377.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"847_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/2045-7022-3-23","volume":"3","author":"C Venter","year":"2013","unstructured":"Venter C, Brown T, Shah N, et al. Diagnosis and management of non-IgE-mediated cow\u2019s milk allergy in infancy - a UK primary care practical guide. Clin Transl Allergy. 2013;3:23. https:\/\/doi.org\/10.1186\/2045-7022-3-23.","journal-title":"Clin Transl Allergy"},{"key":"847_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13223-021-00583-w","volume":"17","author":"A Chomyn","year":"2021","unstructured":"Chomyn A, Chan ES, Yeung J, Vander Leek TK, Williams BA, Soller L, et al. Canadian food ladders for dietary advancement in children with IgE mediated allergy to milk and\/or egg. Allergy Asthma Clin Immunol. 2021;17:83. https:\/\/doi.org\/10.1186\/s13223-021-00583-w.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"847_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/pai.13115","volume":"30","author":"L Gotesdyner","year":"2019","unstructured":"Gotesdyner L, Zeldin Y, Machnes Maayan D, Efron A, Stauber T, Maoz Segal R, et al. A structured graduated protocol with heat denatured eggs in the treatment of egg allergy. Pediatr Allergy Immunol. 2019;30:824\u201332. https:\/\/doi.org\/10.1111\/pai.13115.","journal-title":"Pediatr Allergy Immunol"},{"key":"847_CR14","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1111\/pai.13541","volume":"32","author":"L Thomas","year":"2021","unstructured":"Thomas L, Belcher J, Phillips R, Preece K, Bhatia R. Use of an egg ladder for home egg introduction in children with IgE-mediated egg allergy. Pediatr Allergy Immunol. 2021;32:1572\u20134. https:\/\/doi.org\/10.1111\/pai.13541.","journal-title":"Pediatr Allergy Immunol"},{"key":"847_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/clt2.12068","volume":"11","author":"S Cotter","year":"2021","unstructured":"Cotter S, Lad D, Byrne A, Hourihane JO. Home-based graded exposure to egg o treat egg allergy. Clin Transl Allergy. 2021;11:2\u20135. https:\/\/doi.org\/10.1002\/clt2.12068.","journal-title":"Clin Transl Allergy"},{"key":"847_CR16","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/cea.14009","volume":"51","author":"SC Leech","year":"2021","unstructured":"Leech SC, Ewan PW, Skypala IJ, Brathwaite N, Erlewyn- LajeunesseM, Heath S, et al. BSACI 2021 guideline for the management of egg allergy. Clin Exp Allergy. 2021;51:1262\u201378. https:\/\/doi.org\/10.1111\/cea.14009.","journal-title":"Clin Exp Allergy"},{"key":"847_CR17","doi-asserted-by":"publisher","first-page":"886094","DOI":"10.3389\/falgy.2022.886094","volume":"3","author":"L De Vlieger","year":"2022","unstructured":"De Vlieger L, Nuyttens L, Matton C, Diels M, Verelst S, Leus J, Coppens K, Sauer K, Dilissen E, Coorevits L, Matthys C, Schrijvers R, Raes M, Bullens DMA. Guided Gradual Egg-Tolerance Induction in Hen\u2019s Egg Allergic Children Tolerating Baked Egg: A Prospective Randomized Trial. Front Allergy. 2022;3:886094. https:\/\/doi.org\/10.3389\/falgy.2022.886094.","journal-title":"Front Allergy"},{"key":"847_CR18","first-page":"1","volume":"00","author":"YM D\u2019Art","year":"2022","unstructured":"D\u2019Art YM, Forristal L, Byrne AM, Fitzsimmons J, Van Ree R, et al. Single low-dose exposure to cow\u2019s milk at diagnosis accelerates cow\u2019s milk allergic infants\u2019 progess on milk ladder programme. Eur J Allergy Clin Immunol. 2022;00:1\u201312.","journal-title":"Eur J Allergy Clin Immunol"},{"issue":"6","key":"847_CR19","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/cea.13366","volume":"49","author":"HB Ball","year":"2019","unstructured":"Ball HB, Luyt D. Home-based cow\u2019s milk reintroduction using a milk ladder in children less than 3 years old with IgE-mediated cow\u2019s milk allergy. Clin Exp Allergy. 2019;49(6):911\u201320.","journal-title":"Clin Exp Allergy"},{"key":"847_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jaci.2009.10.060","volume":"125","author":"L Cox","year":"2010","unstructured":"Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: the World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. J Allergy Clin Immunol. 2010;125:569\u201374. 574e1-574.e7.","journal-title":"J Allergy Clin Immunol"},{"key":"847_CR21","doi-asserted-by":"publisher","unstructured":"Soller L, Abrams EM, Carr S, Kapur S, Rex GA, Leo S, Lidman PG, Yeung J, Vander Leek TK, McHenry M, Wong T, Cook VE, Hildebrand KJ, Gerstner TV, Mak R, Lee NJ, Cameron SB, Chan ES. First Real-World Safety Analysis of Preschool Peanut Oral Immunotherapy. J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2759\u20132767e5. https:\/\/doi.org\/10.1016\/j.jaip.2019.04.010. Epub 2019 Apr 17. PMID: 31002957.","DOI":"10.1016\/j.jaip.2019.04.010"},{"key":"847_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13223-022-00696-w","volume":"18","author":"GT Chua","year":"2022","unstructured":"Chua GT, Chan ES, Yeung J, et al. Patient selection for milk and egg ladders using a food ladder safety checklist. Allergy Asthma Clin Immunol. 2022;18:51. https:\/\/doi.org\/10.1186\/s13223-022-00696-w.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"4","key":"847_CR23","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jaci.2020.05.040","volume":"146","author":"EH Kim","year":"2020","unstructured":"Kim EH, Perry TT, Wood RA, Leung DYM, Berin MC, Burks AW, Cho CB, Jones SM, Scurlock A, Sicherer SH, Henning AK, Dawson P, Lindblad RW, Plaut M, Sampson HA, Consortium for Food Allergy Research (CoFAR). Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy. J Allergy Clin Immunol. 2020;146(4):851\u2013862e10. Epub 2020 Jun 12. PMID: 32535135; PMCID: PMC7554054.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-023-00847-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-023-00847-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-023-00847-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T14:04:49Z","timestamp":1699279489000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/s13223-023-00847-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,6]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["847"],"URL":"https:\/\/doi.org\/10.1186\/s13223-023-00847-7","relation":{},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,6]]},"assertion":[{"value":"5 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was granted from the Research Ethics Board at the University of British Columbia (UBC C&W number H19-04044).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The other authors declare that they have no competing interests. ESC has received research support from DBV Technologies; has been a member of advisory boards for Pfizer, Miravo, Medexus, Leo Pharma, Kaleo, DBV, AllerGenis, Sanofi Genzyme, Bausch Health, Avir Pharma, AstraZeneca, ALK; is a member of the healthcare advisory board for Food Allergy Canada; and was co-lead of the CSACI oral immunotherapy guidelines. JY received speaking honoraria from UBC CPD, Sanofi, AstraZeneca, Pfizer, Stallergenes Greer, Novartis, Pediapharm, Medexus Pharma. She has served on advisory\/consultancy committees for Sanofi, Pfizer, HealthLinkBc, Stallergenes Greer, and LEO Pharma. TV has served on advisory boards and received honoraria from Aralez, Bausch Health, and Pfizer. EA served on the Healthcare advisory board, and Food Allergy Canada. She received moderator\/speaker fees from Novartis, GSK, and AstraZeneca. RM was a moderator\/speaker for Astra Zeneca, Pediapharm, and Novartis. He has been on advisory boards for Sanofi, and ALK.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}